NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 3, 2024 — Clene (NASDAQ: CLNN) is revolutionizing treatment for neurodegenerative diseases with its lead agent, CNM-Au8, targeting the NAD+ pathway to improve cellular energy production and utilization. Extensive clinical trials have shown CNM-Au8's strong safety profile, positioning Clene as a leader in addressing ALS and MS.
September 3, 2024 — GeoVax Labs CEO to present at investor events, highlighting the latest developments in biotechnology and clinical trials for COVID-19 vaccine and cancer therapy.
September 3, 2024 — Mainz BioMed CFO discusses the company's commitment to saving lives through early disease detection and prevention, including genetic and genomic tests. Learn more about their progress and promising data from recent trials.
September 3, 2024 — Mainz Biomed's breakthrough colorectal cancer test offers hope for improved early detection and survival rates, potentially impacting the multi-billion dollar U.S. market for colorectal screening and expanding into other gastrointestinal cancers.
September 3, 2024 — REMsleep Holdings, Inc. receives new patent allowance and prepares for product launches, signaling growth and innovation in sleep apnea treatment.
September 3, 2024 — The 2024 Live Your Lyrics event brings together music, unity, and a profound mission to break the silence on suicide, foster open conversations, and support those in need. Join the event to unite for a critical cause and embrace hope for change.
September 2, 2024 — Discover the strategic appeal of the Health Care Select Sector SPDR Fund (XLV) in providing diversified exposure to the U.S. healthcare sector. Learn about the significance of healthcare in the economy and the investment opportunities it presents.
August 31, 2024 — Harper Ellsworth Advertising and Texas Radiotherapy recognized as finalists for the 2024 MM+M Awards, showcasing outstanding work in healthcare marketing and raising awareness about prostate cancer.
August 29, 2024 — Clene's CNM-Au8 trials for ALS and MS treatment show promise for improving patient outcomes. The innovative approach could have a significant impact on the therapeutic market.
August 29, 2024 — Syntekabio introduces 'Develop Now, Pay Later' offer to minimize risk, save time and costs, and increase the success rate of companies developing novel therapies.
August 29, 2024 — Monogram Orthopedics prepares to launch its next-gen surgical robot, positioning itself to capitalize on the growing orthopedic surgery robotic market. Surgeons discuss the impact of the company's technology on patient care and outcomes.
August 29, 2024 — Nuvectis Pharma has achieved a significant milestone with the FDA granting Orphan Drug Designation for NXP800, a potential game-changer in oncology. This news highlights the urgent need for innovative treatments in rare cancers, offering hope for patients and strategic benefits for the company.
August 29, 2024 — Aclarion expands CLUE Trial to New Jersey with Dr. Justin Kubeck joining the network of surgeons. The trial aims to identify how often Nociscan's AI data changes the initial treatment plan for patients with chronic low back pain.
August 29, 2024 — SaveRxCanada.to announces free shipping on all orders through its International Generics Program, making affordable medications even more accessible for customers. The initiative highlights the value of generic medications, offering up to 85% savings compared to brand-name versions.
August 29, 2024 — Read the inspiring story of Eliezer and Tzirel Miller's journey through their daughter's lymphatic malformation diagnosis. Discover hope, resilience, and unwavering faith in the face of adversity.
August 29, 2024 — GeoVax Labs, Inc. announces a securities purchase agreement with an institutional investor, securing funding for the development of immunotherapies and vaccines against cancer and infectious diseases.
August 28, 2024 — iCoreConnect Inc. partners with Alaska Dental Society and endorses nine products, expanding its presence and driving efficiency in dental practices. The endorsement provides lead generation opportunities and an effective distribution channel for iCoreConnect.
August 28, 2024 — Monogram Technologies (NASDAQ: MGRM) forms strategic partnership with Shalby Limited for robotic orthopedic surgery clinical trial, signaling a major advancement in the industry and potential future collaborations.
August 28, 2024 — Statistics Canada data reveals that 45% of Canadians are struggling with rising prices, impacting their day-to-day expenses and mental health. This news sheds light on the widespread impact and highlights the need for solutions.
August 28, 2024 — PathAI's AISight Dx Image Management System is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis, paving the way for European market expansion and improving diagnostic accuracy and patient outcomes.